Status epilepticus: 30 mg rectal diazepam was effective in preventing further seizures
|
|
|
Clinical bottom line (level 1b)
-
More patients in status epilepticus who had 30 mg of diazepam pr compared with 20 mg stopped fitting
(NNT =
2
at 24
hours)
|
|
Remy et al:
Epilepsia
1992;
33 (2):
353-358
|
Expires
September 2003
|
The study
Unblinded ?concealed randomised
trial
without
intention-to-treat
Setting: Specialist epilepsy centre
39 patients
(aged
mean age 31 ± 8,
35%
female)
- simple or complex partial seizures in a series of at least 20 minutes
- two generalised tonic-clonic seizures in 20 minutes
Excluded if
GI, renal or cardiac disorder
body weight-height discrepancy
Control Group: (n = 21, 21 analysed):
20 mg intrarectal diazepam
Experimental Group: (n = 18, 18 analysed):
30 mg intrarectal diazepam
100% followed for
24
hours
stopping repeated seizures
The evidence
| Outcome |
Time to outcome |
CER | EER | RRR (95% CI) | ARR (95% CI) | NNT (95% CI) |
| Seizure stopped
|
minutes |
6 (28.8%) |
13 (72.2%) |
61.0% (14% to
82%) |
43.7% (15.3% to
72.0%) |
2
(1 to
7)
|
| Outcome |
Control Group (SD) |
Experimental Group (SD) |
Mean Difference (95% CI) |
| Total to end of convulsion in minutes
|
7.5
(5)
|
11.2
(9.1)
|
3.7
(-0.98 to 8.38)
|
Citation
-
Remy
C,
Jourdil
N,
Villemain
D, et al:
Intrarectal Diazepam in Epileptic Adults.
Epilepsia
1992;
33 (2):
353-358
Contributor: Christopher Ball and Musab Hayatli,
Unknown Month 2000
Reviewer:
Clinical Question.
| Patient |
status epilepticus |
| Intervention or Exposure |
pr diazepam, 20 mg |
| Comparison |
pr diazepam, 30mg |
| Outcome |
cessation of seizure |
|
|